2 3 8. VERTICAL RIGHT TO DESIGNATE DIRECTORS. Prior to the Effective Time, so long as Vertical owns beneficially (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934 (the "Exchange Act")) at least fifty percent (50%) of the...Termination and Modification Agreement • October 24th, 1996 • Uroquest Medical Corp • Electromedical & electrotherapeutic apparatus • New York
ContractTermination and Modification Agreement • September 1st, 2006
Re: “Exclusive Channel Collaboration Agreement” executed Oct. 5, 2012 by and between Fibrocell Science, Inc. (“Fibrocell”) and Intrexon Corporation (“Intrexon”), as amended and as further amended and modified by that certain letter agreement, dated...Termination and Modification Agreement • May 28th, 2021 • Castle Creek Biosciences, Inc. • Pharmaceutical preparations
This letter agreement constitutes the Termination and Modification Agreement as defined in the Letter Agreement, pursuant to which the Parties shall mutually agree to terminate the ECC, convert the ECC into a product license between Fibrocell and Precigen with regard to the Retained Products and clarify certain items. Please note that, per our recent public announcement, Intrexon has officially been renamed Precigen, Inc. (“Precigen”) and has assigned and consolidated its human health therapeutic development operations, including all of its operations relevant to the ECC, to and within its wholly owned subsidiary PGEN Therapeutics, Inc. (“PGEN”). Unless otherwise specified, references to Fibrocell in this Termination and Modification Agreement shall refer to both Fibrocell and its parent, Castle Creek Biosciences, Inc. (“CCB”), and references to Precigen in this Termination and Modification Agreement shall be deemed to encompass references to Intrexon prior to its having been renamed P
ContractTermination and Modification Agreement • March 14th, 2016
TERMINATION AND MODIFICATION AGREEMENTTermination and Modification Agreement • April 29th, 2009 • BlueLinx Holdings Inc. • Wholesale-lumber, plywood, millwork & wood panels • Georgia
THIS TERMINATION AND MODIFICATION AGREEMENT (this “Agreement”), effective as of the opening of business on April 27, 2009 (the “Effective Date”), is made and entered into by and among Georgia-Pacific LLC (f/k/a Georgia-Pacific Corporation) (“GP”), BlueLinx Corporation and BlueLinx Services, Inc. (together with BlueLinx Corporation, “BlueLinx”). Capitalized terms not otherwise defined herein shall have the same meaning as in that certain Master Purchase, Supply and Distribution Agreement (the “Master Agreement”), dated May 7, 2004, by and among GP and BlueLinx, including all exhibits, schedules and amendments thereto.
EXHIBIT 10-AN(i) TERMINATION AND MODIFICATION AGREEMENT -------------------------------------- THIS AGREEMENT made this 23 day of OCTOBER, 1996, by and between Howard Opera House Associates, a Vermont limited partnership ("Lessor"), whose address is...Termination and Modification Agreement • January 24th, 1997 • Quality Dining Inc • Retail-eating places
AMENDMENT TO TERMINATION AND MODIFICATION AGREEMENTTermination and Modification Agreement • June 10th, 1999 • Cavion Technologies Inc • Delaware
ContractTermination and Modification Agreement • January 12th, 2011
January 31, 2006 Mr. John P. O'Shea President and CEO WESTMINSTER SECURITIES CORPORATION 100 Wall Street 7th Floor New York, NY 10005 REF: TERMINATION AND MODIFICATION OF ENGAGEMENT LETTER Dear Mr. O'Shea: This Termination and Modification Agreement...Termination and Modification Agreement • April 25th, 2006 • Stem Cell Therapy International, Inc.
This Termination and Modification Agreement ("Termination Agreement") modifies, amends and terminates that certain Engagement Letter dated May 4, 2005 ("Engagement Letter") pursuant to which Stem Cell Therapy International Corp. ("SCTI") agreed to engage Westminster Securities Corporation ("Westminster") in connection with certain investment banking and financial advisory services.
ContractTermination and Modification Agreement • June 29th, 2004
